You are here

Article info

Article menu
Download PDFPDF
Editorial commentaries
Dopamine agonist withdrawal syndrome (DAWS): perils of flicking the dopamine ‘switch’

Authors

  1. Correspondence to Dr Mark J Edwards, Sobell Department, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK; m.j.edwards{at}ucl.ac.uk
View Full Text

Citation

Edwards MJ
Dopamine agonist withdrawal syndrome (DAWS): perils of flicking the dopamine ‘switch’
Journal of Neurology, Neurosurgery & Psychiatry 2013;84:120.

Publication history

  • Accepted August 13, 2012
  • First published September 19, 2012.
Online issue publication 
April 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions